BIO-key shareholders approve issuance of up to 1,236,668 shares at annual meeting
BKYI•BIO-key International shareholders approved issuing up to 1,236,668 common shares upon warrant exercise at the October 30, 2026 annual meeting.
BKYI•BKYI•BKYI•BIO-key International shareholders approved issuing up to 1,236,668 common shares upon warrant exercise at the October 30, 2026 annual meeting.
Shareholders approved issuing up to 1,236,668 common shares upon exercise of warrants issued in an August 10, 2026 warrant inducement transaction. The meeting initially convened on September 3 and reconvened on October 2, when shareholders approved three other proposals.
